Search research articles
Contact Us
Filters
Showing results (101-110 of 120) with videos related to
Page
of 12
Sort By:
European Journal of Endocrinology
|
November 13, 2013
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
C Giavoli, E Profka, E Sala, et al.
European Journal of Endocrinology
|
April 9, 2009
Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments
C L Ronchi, C Giavoli, E Ferrante, et al.
Journal of the Endocrine Society
|
July 1, 2021
Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study
E Sala, E Malchiodi, G Carosi, et al.
Cancer Letters
|
October 19, 2020
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
R Catalano, E Giardino, D Treppiedi, et al.
Archives of Osteoporosis
|
August 29, 2018
Progressive bone impairment with age and pubertal development in neurofibromatosis type I
Giulia Rodari, G Scuvera, F M Ulivieri, et al.
Journal of Endocrinological Investigation
|
September 13, 2008
Adrenal morpho-functional alterations in patients with acromegaly
C Scaroni, R Selice, S Benedini, et al.
Journal of Endocrinological Investigation
|
November 28, 2019
Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series
A L Serban, G Del Sindaco, E Sala, et al.
Clinical Endocrinology
|
June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
C L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology
|
September 17, 2009
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function
F Ermetici, F Donadio, L Iorio, et al.
Cancer Letters
|
August 23, 2017
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells
E Peverelli, R Catalano, E Giardino, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 120) with videos related to
Sort By:
Page
of 12
European Journal of Endocrinology
|
November 13, 2013
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
C Giavoli, E Profka, E Sala, et al.
European Journal of Endocrinology
|
April 9, 2009
Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments
C L Ronchi, C Giavoli, E Ferrante, et al.
Journal of the Endocrine Society
|
July 1, 2021
Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study
E Sala, E Malchiodi, G Carosi, et al.
Cancer Letters
|
October 19, 2020
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
R Catalano, E Giardino, D Treppiedi, et al.
Archives of Osteoporosis
|
August 29, 2018
Progressive bone impairment with age and pubertal development in neurofibromatosis type I
Giulia Rodari, G Scuvera, F M Ulivieri, et al.
Journal of Endocrinological Investigation
|
September 13, 2008
Adrenal morpho-functional alterations in patients with acromegaly
C Scaroni, R Selice, S Benedini, et al.
Journal of Endocrinological Investigation
|
November 28, 2019
Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series
A L Serban, G Del Sindaco, E Sala, et al.
Clinical Endocrinology
|
June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
C L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology
|
September 17, 2009
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function
F Ermetici, F Donadio, L Iorio, et al.
Cancer Letters
|
August 23, 2017
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells
E Peverelli, R Catalano, E Giardino, et al.
Page
of 12